997z4m28.200x156x1

ECRI BACKGROUND

The European Cardiovascular Research Institute (ECRI) was founded in 2012 as a European collaborative effort to perform investigator-initiated studies in the field of cardiology. ECRI provides a structure facilitating the design and conduct of clinical trials without the intention of making profit, yet according to ICH and GCP guidelines, and regulatory standards. This unique initiative between thought leaders in the field of cardiology and Cardialysis, with its expertise in the field, creates an opportunity for multicenter, multinational investigator-initiated studies. Several multicenter randomized clinical trials with ECRI acting as trial “sponsor” are currently being conducted by means of scientific grants form leading industries.

ECRI RATIONALE

In the current clinical development environment there is less money available for clinical research. On top of that regulatory requirements and company standard operating procedures make clinical trials expensive to execute. As a result single companies cannot afford studies on treatment strategies, and many interesting study ideas from individual Investigators will not be funded due to budget limitations. With that current clinical environment in mind the European Cardiovascular Research Institute (ECRI) was established to act as intermediate between academic thought leaders and supporting industry. ECRI is a collaborative effort between Investigators and Cardialysis; ECRI takes the role as sponsor for Investigator Sponsored Studies and controls the clinical research project(s), without the intention to make profit.

ECRI VISION

Clinical research in the field of cardiovascular medicine should be initiated by a collaborative group of clinical researchers and performed according to GCP guidelines.

ECRI MISSION

ECRI is a non-profit organization that brings together expert clinical researchers and supporting industries in order to perform clinical studies to improve health care and expenditure in the cardiovascular field and to perform these clinical studies according to international regulations and within pre-defined budgets and timelines